Cargando…
Hydroxyurea Could Be a Good Clinically Relevant Iron Chelator
Our previous study showed a reduction in serum ferritin of β-thalassemia patients on hydroxyurea therapy. Here we aimed to evaluate the efficacy of hydroxyurea alone and in combination with most widely used iron chelators like deferiprone and deferasirox for reducing iron from experimentally iron ov...
Autores principales: | Italia, Khushnooma, Colah, Roshan, Ghosh, Kanjaksha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857323/ https://www.ncbi.nlm.nih.gov/pubmed/24349400 http://dx.doi.org/10.1371/journal.pone.0082928 |
Ejemplares similares
-
Comparison of in-vitro and in-vivo response to fetal hemoglobin production and γ-mRNA expression by hydroxyurea in Hemoglobinopathies
por: Italia, Khushnooma, et al.
Publicado: (2013) -
Iron chelators or therapeutic modulators of iron overload: Are we anywhere near ideal one?
por: Ghosh, Kanjaksha, et al.
Publicado: (2018) -
Should every Patient with MDS get Iron Chelation – Probably Yes
por: Ghosh, Kanjaksha, et al.
Publicado: (2017) -
Effect of inherited red cell defects on growth of Plasmodium falciparum: An in vitro study
por: Pathak, Vrushali, et al.
Publicado: (2018) -
Effect of Cis Acting Potential Regulators in the β Globin Gene Cluster on the Production of HbF in Thalassemia Patients
por: Dabke, Pooja, et al.
Publicado: (2013)